AR003979A1 - Administracion transdermica de vorozol. - Google Patents

Administracion transdermica de vorozol.

Info

Publication number
AR003979A1
AR003979A1 ARP960103972A AR10397296A AR003979A1 AR 003979 A1 AR003979 A1 AR 003979A1 AR P960103972 A ARP960103972 A AR P960103972A AR 10397296 A AR10397296 A AR 10397296A AR 003979 A1 AR003979 A1 AR 003979A1
Authority
AR
Argentina
Prior art keywords
vorozole
patches
vorozol
drug
transdermic administration
Prior art date
Application number
ARP960103972A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR003979A1 publication Critical patent/AR003979A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Parches médicos para la administración transdérmica de vorozol a través de la piel intacta, durante un período de tiempo prolongado, que comprende: (a)una provisión de droga (1) que comprende vorozol (I) y preferentemente un intensificador depenetración en la piel (II) para vorozol, en cantidadessuficientes como para administrar (I) a una proporción terapéuticamente efectiva durante dicho período de tiempo, y (b) un respaldo impermeable a ladroga (2); métodos para el tratamientode paciente con dichos parches; proceso para la fabricación de dichos parches.
ARP960103972A 1995-08-14 1996-08-13 Administracion transdermica de vorozol. AR003979A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95202204 1995-08-14

Publications (1)

Publication Number Publication Date
AR003979A1 true AR003979A1 (es) 1998-09-30

Family

ID=8220567

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103972A AR003979A1 (es) 1995-08-14 1996-08-13 Administracion transdermica de vorozol.

Country Status (4)

Country Link
AR (1) AR003979A1 (es)
AU (1) AU6821196A (es)
WO (1) WO1997006788A1 (es)
ZA (1) ZA966842B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302289B1 (it) * 1998-09-30 2000-09-05 Univ Catania Composizioni farmaceutiche ad attivita' antineoplastica
US6277401B1 (en) * 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
WO2001001951A1 (en) * 1999-07-06 2001-01-11 The Procter & Gamble Company Sheet-like devices
AU3246000A (en) * 1999-07-06 2001-01-22 Procter & Gamble Company, The Cosmetic or dermapharmaceutical patch
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
AU2004220541B2 (en) 2003-03-12 2009-03-26 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
DE102010046464A1 (de) 2009-03-19 2011-04-21 Amw Gmbh Transdermales System mit Aromatasehemmer
DE102010026883A1 (de) 2010-03-11 2011-12-15 Amw Gmbh Transdermales System mit Aromatasehemmer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
NZ224714A (en) * 1987-06-01 1990-03-27 Janssen Pharmaceutica Nv Substituted benzotriazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
GB2256135B (en) * 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
EP0593807A1 (en) * 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤

Also Published As

Publication number Publication date
WO1997006788A1 (en) 1997-02-27
AU6821196A (en) 1997-03-12
ZA966842B (en) 1998-02-16

Similar Documents

Publication Publication Date Title
ES2137261T3 (es) Administracion transdermica de oxibutinina.
TW427908B (en) Pharmaceutical composition for the treatment of fungal diseases in nails and bandages containing the same
HU9200517D0 (en) Process and apparatus for the transdermal portioning of dexmetomidine
HUT56493A (en) Trnasdermal system for transdermal administration of nicotine and process for producing same
ES2186693T3 (es) Uso combinado del acido hialuronico y de agentes terapeuticos para mejorar el efecto terapeutico.
DE69736745D1 (de) Verfahren zur behandlung von prostaterkrankungen unter verwendung von vitamin-d-formulierungen mit verzögerter und/oder verlängerter wirkstofffreigabe
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
ATE78169T1 (de) Behandlung von diabetes durch kombinierte insulinformen.
PT946151E (pt) Forma de dosagem de dose crescente
ES550011A0 (es) Un metodo de administracion de una cantidad terapeuticamenteefectiva de timolol
DE59808186D1 (de) Transdermales therapeutisches system zur abgabe von hormonen
AR003979A1 (es) Administracion transdermica de vorozol.
AR003413A1 (es) Parches medicinales para la administracion transdermica de risperidona con liberacion controlada a traves de la piel intacta durante un periodo de tiempo prolongado
YU71293A (sh) Transdermalni terapijski sistem za davanje fizostigmina na koži i postupak za njegovu izradu
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
SE9101341D0 (sv) New medicinal use
HK1003422A1 (en) A method of treating liver disease and like indications with vasodilating agents
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору
NO941314L (no) Anordning for transdermal administrering av melatonin